Home/Filings/4/0001790300-19-000005
4//SEC Filing

Eggenberg Michael 4

Accession 0001790300-19-000005

CIK 0001453593other

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 5:02 PM ET

Size

6.6 KB

Accession

0001790300-19-000005

Insider Transaction Report

Form 4
Period: 2019-10-30
Eggenberg Michael
Director10% Owner
Transactions
  • Award

    Common Stock, $0.000001 par value

    2019-10-30+20,83320,833 total
Footnotes (3)
  • [F1]These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and will vest and become issuable on February 15, 2020, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.
  • [F2]The Reporting Person is an employee of OrbiMed Advisors LLC ("Advisors"), a registered adviser under the Investment Advisors Act of 1940, as amended. Upon vesting of the restricted stock unit award, ownership of the shares underlying the restricted stock unit award will be transferred to ROS Acquisition Offshore LP ("ROS Acquisition") and OrbiMed Royalty Opportunities II, LP ("ORO II"). Advisors is the investment manager of ROS Acquisition. Advisors is also the investment manager of Royalty Opportunities S.a.r.l., of which ROS Acquisition is a wholly-owned subsidiary. OrbiMed ROF II LLC ("ROF II") is the sole general partner of ORO II, and Advisors is the sole managing member of ROF II. By virtue of such relationships, Advisors may be deemed to have voting and investment power with respect to the securities held by ROS Acquisition and ORO II and, as a result, may be deemed to have beneficial ownership over such securities.
  • [F3]Each of ROS Acquisition, ORO II, Advisors, and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act or for any other purposes.

Issuer

Xtant Medical Holdings, Inc.

CIK 0001453593

Entity typeother

Related Parties

1
  • filerCIK 0001732521

Filing Metadata

Form type
4
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 5:02 PM ET
Size
6.6 KB